I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
mTOR inhibition and T-DM1 in HER2-positive breast cancer:
Casadevall Aguilar, David
;
Hernández Prat, Anna, 1984-
;
García-Alonso, Sara
...
Mol Cancer Res. 2022 Jul 6;20(7):1108-21. ,
Link:
http://hdl.handle.net/10230/54481
RT Journal T1
mTOR inhibition and T-DM1 in HER2-positive breast cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftupompeufabra:oai:repositori.upf.edu:10230_54481&Exemplar=1&LAN=DE A1 Casadevall Aguilar, David A1 Hernández Prat, Anna, 1984- A1 García-Alonso, Sara A1 Arpí Llucià, Oriol A1 Menéndez, Silvia A1 Qin, Mengjuan A1 Guardia Valenzuela, Cristina, 1990- A1 Morancho Armisen, Beatriz A1 Sánchez-Martín, Francisco Javier A1 Zazo, Sandra A1 Gavilán, Elena A1 Sabbaghi Mehrjardi, Mohammad Ali A1 Eroles, Pilar A1 Cejalvo, Juan M A1 Lluch, Ana A1 Rojo, Federico A1 Pandiella, Atanasio A1 Rovira, Ana A1 Albanell Mestres, Joan PB American Association for Cancer Research (AACR) K1 Inhibition of mTOR increases the antitumor activity of T-DM1 K1 Supporting that the combination of mTOR inhibitors K1 Antibody-drug conjugates warrants clinical evaluation in patients with HER2-positive breast cancer JF Mol Cancer Res. 2022 Jul 6;20(7):1108-21 LK http://hdl.handle.net/10230/54481 DO http://hdl.handle.net/10230/54481 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)